Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital

Singapore Medical Journal

Volumn 46, Issue 9, 2005, Pages 450-456

  Chng, Wee Joo ^a,b   Sum, C ^a   Kuperan, P ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Coagulation factors; Fresh frozen plasma; Lupus anticoagulant; Prolonged activated partial thromboplastin time

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FRESH FROZEN PLASMA; LUPUS ANTICOAGULANT; PROTHROMBIN; THROMBIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD ANALYSIS; BLOOD CLOTTING FACTOR DEFICIENCY; CONTROLLED STUDY; FEMALE; GENERAL HOSPITAL; HEMOSTASIS; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; POPULATION RESEARCH; PROTHROMBIN TIME; THROMBIN TIME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION DISORDERS; FEMALE; HEMORRHAGIC DISORDERS; HOSPITALS, GENERAL; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PLASMA; PROSPECTIVE STUDIES; PROTHROMBIN TIME; RISK ASSESSMENT; RISK FACTORS; SINGAPORE; TIME FACTORS;

EID: 24344482520     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin: a simple screening test for first stage clotting factor deficiencies. Am J Clin Pathol 1961; 36:212-9.
2. Basu D, Gallus A, Hirsh J, et al. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972; 287:324-7.
3. Mant MJ, King EG. Severe, acute disseminated intravascular coagulation. A reappraisal of its pathophysiology, clinical significance and therapy based on 47 patients. Am J Med 1979; 67:557-63.
4. Rapaport SIL. Preoperative hemostatic evaluation: which tests, if any? Blood 1983; 61:229-31.
5. Chng WJ, Tan MK, Kuperan P. An audit of fresh frozen plasma usage in an acute general hospital in Singapore. Singapore Med J 2003; 44:574-8.
6. McPhedron P, Clyne LP, Ortoli NA, et al. Prolongation of the activated partial thromboplastin time associated with poor venipuncture technic. Am J Clin Pathol 1974; 62:16-20.
7. Joist JH, Cowan JF, Khan M. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording. J Lab Clin Med 1977; 90:1054-65.
8. Czepek EE. Editorial: Iatrogenic prolonged aPTT: a nondisease state. JAMA 1974; 227:1304.
9. Koepke JA, Rodgers JL, Ollivier MJ. Pre-instrumental variables in coagulation testing. Am J Clin Pathol 1975; 64:591-6.
10. Laffan MA, Bradshaw AE. Investigation of haemostasis. In: Dacie JV, Lewis SM, eds. Practical Haematology. New York: Churchill Livingstone 1995:297-315.
11. Green D, Hougie C, Kazmier FJ, et al. Report of the working party on acquired inhibitors of coagulation: studies of the 'lupus' anticoagulant. Thromb Haemost 1983; 49:144-6.
12. Gallimore MJ, Jones DW, Winter M. Factor XII, determinations in the presence and absence of phospholipid antibodies. Thromb Haemost 1998; 79:87-90.
13. Kitchens CS. Prolonged activated partial thromboplastin time of unknown aetiology: a prospective study of 100 consecutive cases referred for consultation. Am J Haematol 1988; 27:38-45.
14. Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101:1827-32.
15. Kitchens CS. The contact system. Arch Pathol Lab Med 2002; 126:1382-6.
16. Halbmayer WM, Haushofer A, Schon R, et al. The prevalence of moderate to severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemost 1994; 71:68-72.
17. Bolton-Maggs PH. Factor XI deficiency and its management. Haemophilia 2000; 6 suppl:100-9.
18. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. JAMA 1994; 271:777-81.
19. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126:11-28.
20. Clarke JR, Eisenberg JM. A theoretical assessment of the value of the PTT as a preoperative screening test in adults. Med Decis Making 1981; 1:40-3.
21. Suchman AL, Griner PF. Diagnostic uses of the activated partial thromboplastin time and prothrombin time. Ann Intern Med 1986; 104:810-6.